Pfizer's drug to treat tuberculosis in short supply - (Yahoo!News via NewsPoints Desk)

  • The FDA added Pfizer's tuberculosis drug rifampin to its list of drugs in short supply, as reported Yahoo!News Monday.
  • The agency, which indicated that the drug will be in short supply through the end of June, blamed the shortage on a manufacturing delay.
  • Pfizer previously alerted doctors earlier this month that some vials of the medicine may fail to meet the specifications for drug potency and that the powder in these vials would be brown or black instead of the expected red.

To read more NewsPoints articles, click here.